Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-25-000085
Filing Date
2025-01-07
Accepted
2025-01-07 19:04:06
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form312227001laz_01072025.html 3  
1 OWNERSHIP DOCUMENT form312227001laz_01072025.xml 3 5156
  Complete submission text file 0000921895-25-000085.txt   6776
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PH THE TOWERS, TOWER 200, 30B WINSTON CHURCHILL, PAITILLA PANAMA CITY R1 07196
Business Address
Lazar David E. (Reporting) CIK: 0001932843 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 25516156